Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy.
Mark Lubow RileyPaul Der MesropianAna MaheshwariMustafa Erdem ArslanParth VisrodiaLoay SalmanRuben Peredo-WendeLlewellyn FoulkeKrishnakumar HongalgiPublished in: Journal of investigative medicine high impact case reports (2022)
Systemic sclerosis with negative serology, particularly that complicated by scleroderma renal crisis (SRC), is rarely encountered. We describe a patient with seronegative systemic sclerosis who developed acute kidney injury, proteinuria, and hypertensive emergency following motor vehicle-related trauma and in the setting of nonsteroidal anti-inflammatory drug use. Findings on physical examination, imaging, and skin biopsy led to a clinical diagnosis of scleroderma, despite the lack of supportive laboratory data. IgG lambda paraproteinemia was detected on workup. Bone marrow biopsy showed plasmacytosis and trace lambda-restricted plasma cells consistent with monoclonal gammopathy of undetermined significance. Chemotherapy was initially started given concern for myeloma with cast nephropathy but was later stopped after a kidney biopsy revealed thrombotic microangiopathy (TMA). The SRC associated with TMA was ultimately diagnosed, though atypical hemolytic uremic syndrome (aHUS) induced perhaps by monoclonal gammopathy or hypertension was also possible. Captopril and eculizumab were initiated for SRC and aHUS, respectively. Despite therapy, renal function did not recover, and the patient required hemodialysis indefinitely. This case highlights clinical features common to both SRC and aHUS as well as points out a few ways to differentiate between them.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- case report
- tyrosine kinase
- public health
- acute kidney injury
- bone marrow
- multiple myeloma
- blood pressure
- ultrasound guided
- anti inflammatory
- fine needle aspiration
- induced apoptosis
- emergency department
- physical activity
- mesenchymal stem cells
- mental health
- risk assessment
- stem cells
- machine learning
- oxidative stress
- big data
- electronic health record
- diabetic rats
- rheumatoid arthritis
- cell cycle arrest
- mass spectrometry
- drug induced
- squamous cell carcinoma
- high glucose
- locally advanced
- radiation therapy
- artificial intelligence
- idiopathic pulmonary fibrosis